https://www.selleckchem.com/pr....oducts/Idarubicin.ht
The objective of this pilot study was to evaluate the change in ****ual function following treatment with fractional CO2 laser therapy in breast cancer (BC) survivors with genitourinary syndrome of menopause (GSM). A single-arm feasibility study of BC survivors with symptoms of GSM, including dyspareunia and/or vaginal dryness, was conducted. Participants who received three treatments with fractional CO2 laser and 4-week follow-up were contacted for patient-reported outcomes and adverse events at 12 months. Sexual function was measure
Beğen
Yorum Yap
Paylaş
